China Manufacturer for Gentamicin Therapy - dexamethasone sodium phosphate injection – Xinanran
China Manufacturer for Gentamicin Therapy - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
With reliable quality process, good reputation and perfect customer service, the series of products produced by our company are exported to many countries and regions for China Manufacturer for Gentamicin Therapy - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: Jeddah, Islamabad, Romania, Thus far, our item associated with printer dtg a4 may be shown in most foreign nations as well as urban centers, which are sought after simply by targeted traffic. We all highly imagine that now we have now the full capacity to present you with contented merchandise. Desire to collect requests of your stuff and produce the long-term co-operation partnership. We very seriously promise:Csame top quality, better price; exact same selling price, higher quality.
In general, we are satisfied with all aspects, cheap, high-quality, fast delivery and good procuct style, we will have follow-up cooperation!







